/ Most Recent /
Celiacs Have an Increased Risk of Cardiovascular Disease
People who have celiac disease may face higher odds of developing cardiovascular disease — even though they often lack the ...
Low Levels of Serine Linked to Peripheral Neuropathy
Diabetic mice with low levels of the amino acid serine have an increased risk for peripheral neuropathy, according to a ...
Wellness From Within Protocol
What’s the secret to improved health and wellness? More than likely, it’s in your gut. It’s well known that a ...
Omega-3s Lower Risk of Kidney Disease
Omega-3 fatty acids from seafood and oily fish — not plants — are linked with a reduced risk of chronic ...
Glucomannan Helps Control Type 2 Diabetes
Glucomannan supplements made from konjac root improve several markers for type 2 diabetes, according to a study in Nutrients. Previous ...
NAFLD Damages the Brain
Patients with non-alcoholic fatty liver disease (NAFLD) have increased odds of depression, dementia, and other neurological conditions, according to a ...
Too Little Choline Is Linked with Alzheimer’s
The research on choline’s brain-boosting benefits keeps building. In the latest study from Aging Cell, researchers have linked a deficiency ...
Ashwagandha Boosts Sexual Function in Women
Ashwagandha helps improve sexual function and desire in women, according to a prospective, randomized, placebo-controlled study in the journal Cureus. ...
5 Steps to Reset Your Microbiota for 2023
The holiday season may be the most joyous time of the year, but all the feasting, partying, and stress that ...
/ Top Articles /
Sorry, we couldn't find any posts. Please try a different search.
/ Weight Loss /
Stopping GLP-1 Receptor Agonists… Why and How to Plan an “Exit Strategy” for Your Patients
In recent years, the pharmaceutical landscape has seen the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) such as semaglutide and tirzepatide, offering promising outcomes in weight reduction for those struggling with obesity. Landmark trials demonstrated significant weight loss in obese individuals. ...
Acknowledging Gender Differences in Obesity Research
With the celebration of International Women’s Day on March 8th, it’s timely to review the differences in women’s health research and how that specifically affects investigations into treatments for overweight and obesity. Obesity and overweight—gender similarities and differences By 2022, 8 billion ...
Researchers Link Abdominal Fat to Brain Health in Men
According to the World Health Organization, some 55 million people globally suffer from Alzheimer’s disease or dementia. With 10 million new cases diagnosed annually, dementia has become the seventh leading cause of death worldwide, and those numbers are only likely to grow ...
Amarasate, An Extract of Bitter Hop Flowers Shown Effective For Weight Loss: The Science And Mode Of Action
With the massive interest in the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the management of both Type 2 diabetes and obesity/overweight, it is timely to review the mode of action of these medications and that of an alternative GLP-1-stimulating nutraceutical. ...
Multiple Human Studies Show Significant Weight-Loss Benefits for Amarasate, A Proprietary Extract of Bitter Hops
A trio of studies performed in the past 5 years shows that a proprietary hops extract called Amarasate can help curb hunger and food cravings.
Supporting Integrative Practitioners Since 2013
